173 related articles for article (PubMed ID: 10463048)
1. Evaluating the impact of reference-based pricing.
Grootendorst P; Holbrook A
CMAJ; 1999 Aug; 161(3):273-4. PubMed ID: 10463048
[No Abstract] [Full Text] [Related]
2. Evaluating reference-based pricing: initial findings and prospects.
Narine L; Senathirajah M; Smith T
CMAJ; 1999 Aug; 161(3):286-8. PubMed ID: 10463052
[TBL] [Abstract][Full Text] [Related]
3. The impact of reference-pricing systems in Europe: a literature review and case studies.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):729-37. PubMed ID: 22098289
[TBL] [Abstract][Full Text] [Related]
4. GP fundholding and the costs of prescribing.
Whynes DK; Baines DL; Tolley KH
J Public Health Med; 1995 Sep; 17(3):323-9. PubMed ID: 8527186
[No Abstract] [Full Text] [Related]
5. [How many diabetic patients in your practice? Important references for regress defense].
MMW Fortschr Med; 2005 Oct; 147(40):48-9. PubMed ID: 16255517
[No Abstract] [Full Text] [Related]
6. Prescribing data and cost comparisons in New Zealand.
Bishop N; Maling T
N Z Med J; 1997 Nov; 110(1056):445-6. PubMed ID: 9418844
[No Abstract] [Full Text] [Related]
7. [Do the fee-for-service and reimbursement influence medical practice?].
Fretheim A; Håvelsrud K; Flottorp S; Oxman AD
Tidsskr Nor Laegeforen; 2003 Mar; 123(6):795-6. PubMed ID: 12693118
[No Abstract] [Full Text] [Related]
8. The economic aspects of drug use.
Haaijer-Ruskamp FM; Dukes MN
WHO Reg Publ Eur Ser; 1993; 45():125-45. PubMed ID: 8442842
[No Abstract] [Full Text] [Related]
9. Canadian prescription drug costs surpass 18 billion dollars.
Morgan S
CMAJ; 2005 May; 172(10):1323-4. PubMed ID: 15883408
[No Abstract] [Full Text] [Related]
10. Prescribing costs.
Malcolm L
N Z Med J; 1998 Mar; 111(1061):83. PubMed ID: 9575063
[No Abstract] [Full Text] [Related]
11. Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference.
Greczyn RJ
N C Med J; 2003; 64(6):285-6. PubMed ID: 14983619
[No Abstract] [Full Text] [Related]
12. [Economic prescription of drugs].
Sonne J; Faber O
Ugeskr Laeger; 2004 Apr; 166(18):1695. PubMed ID: 15174414
[No Abstract] [Full Text] [Related]
13. [Evaluation of prescription practices and of the rational use of medicines in Niger].
Mallet HP; Njikam A; Scouflaire SM
Sante; 2001; 11(3):185-93. PubMed ID: 11641083
[TBL] [Abstract][Full Text] [Related]
14. [A shock for 348 colleagues. Penalties up to 400,000 euro].
Schmidt K
MMW Fortschr Med; 2005 Jun; 147(22):40-2. PubMed ID: 15977633
[No Abstract] [Full Text] [Related]
15. [Quality reports reduce drug costs in primary health care. Stockholm County Council a model for decentralized expenditure responsibility].
Almkvist H; Bergman U; Edlert M; Juhasz-Haverinen M; Pehrsson A; Bergen-Dahl GT; Veg A; Wettermark B
Lakartidningen; 2008 Oct 15-21; 105(42):2930-4. PubMed ID: 19025150
[No Abstract] [Full Text] [Related]
16. The cost of drugs: a policy conundrum of global proportions.
Barry DR; Romig B
N C Med J; 2003; 64(6):287-8. PubMed ID: 14983620
[No Abstract] [Full Text] [Related]
17. Rethinking prescribing in the United States.
Ellner A
BMJ; 2003 Dec; 327(7428):1397-400. PubMed ID: 14670892
[TBL] [Abstract][Full Text] [Related]
18. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
19. Health financing policies. Providers' opinions and prescribing behavior in rural China.
Dong H; Bogg L; Rehnberg C; Diwan V
Int J Technol Assess Health Care; 1999; 15(4):686-98. PubMed ID: 10645110
[TBL] [Abstract][Full Text] [Related]
20. [Reduce prescription of expensive drugs without increased value].
Furberg C
Lakartidningen; 2003 Dec; 100(49):4113. PubMed ID: 14717079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
